CTLA4 and neoplasm: Treatment of MDA-MB-231-luc-bearing mice with either a-CTLA-4 alone or the combination of a-CTLA-4 and a-PD-1 mAbs failed to inhibit tumor growth or lung metastases compared with untreated animals (Fig. 5a–c).